Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non Operating Income (2020 - 2025)

Maravai Lifesciences Holdings has reported Non Operating Income over the past 6 years, most recently at -$43000.0 for Q4 2025.

  • Quarterly results put Non Operating Income at -$43000.0 for Q4 2025, down 200.0% from a year ago — trailing twelve months through Dec 2025 was -$4.2 million (down 77.36% YoY), and the annual figure for FY2025 was -$4.2 million, down 77.36%.
  • Non Operating Income for Q4 2025 was -$43000.0 at Maravai Lifesciences Holdings, up from -$71000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for MRVI hit a ceiling of $914000.0 in Q4 2022 and a floor of -$4.1 million in Q2 2025.
  • Median Non Operating Income over the past 5 years was $15500.0 (2022), compared with a mean of -$395450.0.
  • Biggest five-year swings in Non Operating Income: skyrocketed 3450.0% in 2021 and later crashed 42400.0% in 2022.
  • Maravai Lifesciences Holdings' Non Operating Income stood at $201000.0 in 2021, then surged by 354.73% to $914000.0 in 2022, then crashed by 94.64% to $49000.0 in 2023, then dropped by 12.24% to $43000.0 in 2024, then tumbled by 200.0% to -$43000.0 in 2025.
  • The last three reported values for Non Operating Income were -$43000.0 (Q4 2025), -$71000.0 (Q3 2025), and -$4.1 million (Q2 2025) per Business Quant data.